LIGAND BASED PHARMACOPHORE DEVELOPMENT FOR COLORECTAL CANCER DRUGS

  • Haseeb M
  • Vaqar S
  • Fazal S
  • et al.
N/ACitations
Citations of this article
5Readers
Mendeley users who have this article in their library.

Abstract

….Objective: Focusing on the drugs used for chemotherapy and their associatedside effects, there is a need to design and develop new anti-colon cancer drugs with lesser sideeffects and improved efficacy. Pharmacophore model proves to be a very helpful tool servingin the designing and development of new lead compounds. Place and Duration: Departmentof Bioinformatics, Mohammad Ali Jinnah University, Islamabad from January 2014 to May2014. Results: In this paper, pharmacophore of 4 novel anti-colon cancer compounds hasbeen identified and validated for the first time. Using LigandScout the pharmacophore featureswere predicted and 3D pharmacophore have been extracted via VMD software. A training setdata was collected from literature and the proposed model was applied to the training setwhereby validating and verifying their similar activity as that of the most active compounds.Conclusions: The pharmacophore model is a very handy tool for new lead compoundsdiscovery and development. In this study pharmacophore models were built for novel drugs ofcolorectal cancer and they could be recommended for further studies

Cite

CITATION STYLE

APA

Haseeb, M., Vaqar, S., Fazal, S., & Khalil, A. (2018). LIGAND BASED PHARMACOPHORE DEVELOPMENT FOR COLORECTAL CANCER DRUGS. The Professional Medical Journal, 21(05), 856–863. https://doi.org/10.29309/tpmj/2014.21.05.2548

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free